[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f9vbGkAWwl1tAvP2CRyZBwTK40UCRUgD5AZ6-ZU6z8Pw":8,"$fRNyGNWgnVFiq20igukeYHRrimGovDtaowt9T3JjGq8U":55,"$fUmRmvp-UbI_A3R-SbyXy49dB8GvvC2xmdJkmY9NGLf0":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},68549,867252,[],"https://ystcdn.venuertc.com/medical/ystApp/3PMFog9SJLbtP3VML2xGXUy2tMSMprgU.png","曾珊珊","潍坊市益都中心医院","血液内科","住院医师",447,0,"急性髓系白血病用药解读：阿扎胞苷与维耐克拉安全用药全指南","","https://ystcdn.venuertc.com/venue/AI/35a33b7a-d08b-4d58-972e-568601099d69.jpg","\u003Cdiv class=\"aml-material-container\">\n  \u003Ch1 id=\"material_title\" class=\"aml-material-title\">急性髓系白血病用药解读：阿扎胞苷与维耐克拉安全用药全指南\u003C/h1>\n  \u003Csection class=\"aml-section-with-bg\">\n    \u003Ch2 class=\"aml-section-title\">为什么要重视阿扎胞苷与维耐克拉的安全用药？\u003C/h2>\n    \u003Cdiv class=\"aml-section-content\">\n      \u003Cp>阿扎胞苷和维耐克拉作为近年应用突出的化疗和靶向药物，被广泛用于血液系统疾病的治疗。很多人可能只听说过药品名称，不太清楚实际如何安全用药、两药联合有哪些讲究、以及服药期间要避开的常见风险。其实，正确使用这类药品有不少细节要特别在意：从服药时间、剂型、相互作用、可能的不良反应，到储存环境，每一步都影响治疗效果。接下来，我们就用7个关键细节，带你了解这两种药品背后的安全用药知识。\u003Cspan class=\"aml-emoji\">💡\u003C/span>\u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"aml-section-with-bg\">\n    \u003Ch2 class=\"aml-section-title\">01. 阿扎胞苷的剂型与服用技巧\u003C/h2>\n    \u003Cdiv class=\"aml-section-content\">\n      \u003Cp>阿扎胞苷（Azacitidine）有注射剂和口服片两种剂型。\u003C/p>\n      \u003Cul>\n        \u003Cli>注射剂需要医疗人员操作，常采用皮下注射或静脉给药方式。不建议自行注射。\u003C/li>\n        \u003Cli>口服片规格常见有100mg，每片需整片吞服，禁止掰开、咀嚼、研碎，以免影响药效。\u003C/li>\n        \u003Cli>服药时应以一杯温水送服，可选餐前或餐后，但要每日时间一致，有助于稳定血药浓度。\u003C/li>\n      \u003C/ul>\n      \u003Cp>正确做法：如为口服片，需在医生指导下严格按剂量服用。若为注射剂，应到医院规范注射。饮水量建议不少于200ml。\u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"aml-section-with-bg\">\n    \u003Ch2 class=\"aml-section-title\">02. 维耐克拉的用法、服用时间与餐食关系\u003C/h2>\n    \u003Cdiv class=\"aml-section-content\">\n      \u003Cp>维耐克拉（Venetoclax）为口服片剂，常见规格是10mg、50mg和100mg。该药有严格的服药流程和固定用药时间窗口。\u003C/p>\n      \u003Cul>\n        \u003Cli>建议每日定时、整片吞服，不可嚼碎、压碎或溶解。\u003C/li>\n        \u003Cli>维耐克拉最好于进食后（如早餐后）服用，能减少胃肠刺激，且高脂餐可能影响药物吸收。\u003C/li>\n        \u003Cli>服药过程中应避免葡萄柚、塞维拉民、柚子等影响肝代谢的食物和饮品。\u003C/li>\n      \u003C/ul>\n      \u003Cp>正确做法：若每日服药应持续相同时间点，并与医生沟通饭前饭后的安排。\u003Cspan class=\"aml-emoji\">⏰\u003C/span>\u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"aml-section-with-bg\">\n    \u003Ch2 class=\"aml-section-title\">03. 药理作用简介：阿扎胞苷与维耐克拉如何发挥作用？\u003C/h2>\n    \u003Cdiv class=\"aml-section-content\">\n      \u003Cp>两药作用机制决定了它们的用药细节：\u003C/p>\n      \u003Cul>\n        \u003Cli>阿扎胞苷属于去甲基化剂，通过抑制DNA甲基转移酶，阻止异常细胞的增殖。\u003C/li>\n        \u003Cli>维耐克拉为BCL-2蛋白抑制剂，可以促使异常细胞凋亡，从而减少有害细胞数量。\u003C/li>\n      \u003C/ul>\n      \u003Cp>这种联合作用机制在多项研究（DiNardo et al., 2020；Pollyea et al., 2019）中被证实能协同增强疗效，但也加大了管理药物毒性的难度，必须注意联合用药方案的调整和依从性。\u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"aml-section-with-bg\">\n    \u003Ch2 class=\"aml-section-title\">04. 正确的联合用药与剂量调整要点\u003C/h2>\n    \u003Cdiv class=\"aml-section-content\">\n      \u003Cp>阿扎胞苷与维耐克拉联合用药存在独特的剂量安排，必须严格依照方案执行：\u003C/p>\n      \u003Cul>\n        \u003Cli>阿扎胞苷常用为每疗程7天皮下/静脉注射，也有口服方案（周期性给药）。\u003C/li>\n        \u003Cli>维耐克拉需\"递增剂量\"起始——通常第一周分级从低量逐渐加至足量，预防肿瘤溶解综合征等不良反应。\u003C/li>\n        \u003Cli>若合并肝、肾功能障碍或出现不良反应，剂量可能需下调或暂缓。\u003C/li>\n      \u003C/ul>\n      \u003Cp>正确做法：绝不可随意增减用药剂量，遇到药品变更应由医生重新计量，按周期复查并评估用药效果。\u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"aml-section-with-bg\">\n    \u003Ch2 class=\"aml-section-title\">05. 药物相互作用重点\u003C/h2>\n    \u003Cdiv class=\"aml-section-content\">\n      \u003Cp>这两种药物与其他药品或食物易产生重要的相互作用：\u003C/p>\n      \u003Cul>\n        \u003Cli>维耐克拉为CYP3A酶代谢，不能与强效CYP3A抑制剂（如酮康唑、克拉霉素）同时服用，否则血药浓度升高，风险大增。\u003C/li>\n        \u003Cli>部分降糖药、血压药、抗真菌药与这两药也有交互作用，应提前汇报给医生。\u003C/li>\n        \u003Cli>维耐克拉避免同时服用葡萄柚汁、石榴汁等影响药物代谢的食物饮品。\u003C/li>\n        \u003Cli>阿扎胞苷与主要食物和绝大部分常规药的相互作用风险较低，但应避免与其它毒性化疗药无医嘱联合。\u003C/li>\n      \u003C/ul>\n      \u003Cp>特别提醒：服用任何新的中成药、保健品、非处方药时，应主动咨询专业药师或医生。\u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"aml-section-with-bg\">\n    \u003Ch2 class=\"aml-section-title\">06. 不良反应监测与处理建议\u003C/h2>\n    \u003Cdiv class=\"aml-section-content\">\n      \u003Cp>据多项临床研究，阿扎胞苷和维耐克拉不良反应各有侧重。常见不良反应及应对方式如下：\u003C/p>\n      \u003Cul>\n        \u003Cli>\u003Cstrong>阿扎胞苷：\u003C/strong>常见有注射部位反应、恶心、呕吐、乏力。遇到持续性不适要及时就医。\u003C/li>\n        \u003Cli>\u003Cstrong>维耐克拉：\u003C/strong>可能引发白细胞减少、血小板减少、感染机会增加，部分患者有腹泻或便秘。\u003C/li>\n      \u003C/ul>\n      \u003Cp>正确做法：用药期间务必定期抽血复查，出现明显出血、发热、持续腹泻应尽早就医处理。\u003Cspan class=\"aml-emoji\">⚠️\u003C/span>\u003C/p>\n      \u003Cp>实际用药案例：有位患者连续4周期联合用药过程中，未出现明显不良反应，疗效评估为部分缓解，但仍需密切监测血象和定期调整用药方案。\u003C/p>\n      \u003Cp>处理原则：轻微胃肠道反应可短时间观察，若症状持续或加重，不应自行停药，需及时联系医生。\u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"aml-section-with-bg\">\n    \u003Ch2 class=\"aml-section-title\">07. 特殊人群用药调整要点\u003C/h2>\n    \u003Cdiv class=\"aml-section-content\">\n      \u003Cp>这两种药品在不同人群中的用量及管理略有区别：\u003C/p>\n      \u003Cul>\n        \u003Cli>\u003Cstrong>老年人：\u003C/strong>常因肾功能或肝功能减退，需要个体化减量，建议用药前做基础功能评估。\u003C/li>\n        \u003Cli>\u003Cstrong>肝肾功能异常者：\u003C/strong>如肝肾功能中、重度受损，药物排泄延迟，应减少剂量并增加监测频率。\u003C/li>\n        \u003Cli>\u003Cstrong>孕妇及哺乳期妇女：\u003C/strong>两种药物均有致畸及哺乳禁用风险，若意外怀孕或需哺乳应主动报告。\u003C/li>\n        \u003Cli>\u003Cstrong>儿童用药：\u003C/strong>目前两药在儿童中的使用安全性与有效性受限，必须在权威医生严格指导下执行个体化方案。\u003C/li>\n      \u003C/ul>\n      \u003Cp>正确做法：出现特殊人群情况时切记不要自行判断剂量，每次用药调整须经临床医生评估。\u003Cspan class=\"aml-emoji\">👨‍⚕️\u003C/span>\u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"aml-section-with-bg\">\n    \u003Ch2 class=\"aml-section-title\">08. 漏服与过量处理方法\u003C/h2>\n    \u003Cdiv class=\"aml-section-content\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>阿扎胞苷：\u003C/strong>若错过注射时间，应尽快与负责医生联系，不建议自行补打。\u003C/li>\n        \u003Cli>\u003Cstrong>维耐克拉：\u003C/strong>忘记服药若距离下次服药时间较长，可及时补服；若快到下一次，则跳过本次，不推荐双倍剂量。\u003C/li>\n        \u003Cli>意外过量：有可能加重骨髓抑制和其他毒性，需尽快就医，理想情况下带上药品说明书包装。\u003C/li>\n      \u003C/ul>\n      \u003Cp>正确做法：切忌盲目补药、叠加剂量，每次用药都要按时记好，用药日记或闹钟提醒是不错的选择。\u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"aml-section-with-bg\">\n    \u003Ch2 class=\"aml-section-title\">09. 储存方法和有效期管理\u003C/h2>\n    \u003Cdiv class=\"aml-section-content\">\n      \u003Cul>\n        \u003Cli>阿扎胞苷注射剂应在2-8℃冰箱冷藏，避免冷冻，开瓶后需在短时间内用完。\u003C/li>\n        \u003Cli>口服片须放在干燥阴凉处，远离儿童。\u003C/li>\n        \u003Cli>维耐克拉片剂常温保存即可，避免高温潮湿。勿将药片分装至其它容器。\u003C/li>\n        \u003Cli>所有药品都应妥善查看生产日期和有效期，过期药物严禁服用，废弃时可送至有资质的回收点或医疗机构。\u003C/li>\n      \u003C/ul>\n      \u003Cp>正确做法：每次取药后就及时密封存放，定期检查药品状态。\u003Cspan class=\"aml-emoji\">🗃️\u003C/span>\u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"aml-section-with-bg\">\n    \u003Ch2 class=\"aml-section-title\">10. 小结与安全用药提醒\u003C/h2>\n    \u003Cdiv class=\"aml-section-content\">\n      \u003Cp>总的来看，阿扎胞苷和维耐克拉作为联合治疗方案，优势在于协同作用与独特的机制。但是，这两种药物都有严格的服用流程、剂量安排和细致的监测要求。强调：\u003C/p>\n      \u003Cul>\n        \u003Cli>严格按医嘱执行用药计划，不随意更改剂量和服药时间。\u003C/li>\n        \u003Cli>出现不良反应、漏服、过量等问题时，不要自行处理，务必联系医生。\u003C/li>\n        \u003Cli>药品的正确储存同样关键，能最大程度保证药效和用药安全。\u003C/li>\n      \u003C/ul>\n      \u003Cp>只有掌握每个细节，才能提升治疗效果、减少用药风险，为健康保驾护航。\u003C/p>\n      \u003Cp>如果家中有亲友正在使用这两类药品，不妨一起了解这些要点，共同守护安全用药。\u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"aml-section-with-bg\">\n    \u003Ch2 class=\"aml-section-title\">主要参考文献\u003C/h2>\n    \u003Cdiv class=\"aml-section-content\">\n      \u003Cul class=\"aml-reference-list\">\n        \u003Cli>DiNardo, C. D., Jonas, B. A., Pullarkat, V., Thirman, M. J., Garcia, J. S., Wei, A. H., ... & Konopleva, M. (2020). Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia. \u003Cem>New England Journal of Medicine, 383\u003C/em>(7), 617-629.\u003C/li>\n        \u003Cli>Pollyea, D. A., Pratz, K. W., Letai, A., Jonas, B. A., Wei, A. H., Pullarkat, V., ... & DiNardo, C. D. (2019). Venetoclax in Combination with Azacitidine or Decitabine in Treatment-Naive, Elderly Patients with Acute Myeloid Leukemia. \u003Cem>Blood, 133\u003C/em>(1), 7-17.\u003C/li>\n        \u003Cli>Bhatnagar, B., & Cheson, B. D. (2021). Use of hypomethylating agents in acute myeloid leukemia: expanding roles. \u003Cem>Hematology/Oncology Clinics, 35\u003C/em>(2), 309-327.\u003C/li>\n        \u003Cli>Venetoclax [package insert]. South San Francisco, CA: Genentech USA, Inc.; 2021.\u003C/li>\n        \u003Cli>Azacitidine [package insert]. Summit, NJ: Celgene Corporation; 2021.\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.aml-material-container {\n  max-width: 900px;\n  margin: 40px auto 40px auto;\n  background: #fafbfc;\n  border-radius: 18px;\n  box-shadow: 0 4px 36px rgba(56, 81, 97, 0.12);\n  padding: 44px 36px 36px 36px;\n  font-family: 'Segoe UI', 'Microsoft YaHei', Arial, sans-serif;\n  font-size: 18px;\n  color: #314659;\n  line-height: 1.78em;\n  letter-spacing: 0.02em;\n  position: relative;\n}\n\n.aml-material-title {\n  font-size: 2.25em;\n  text-align: center;\n  margin-bottom: 42px;\n  font-weight: bold;\n  color: #205082;\n  letter-spacing: 2px;\n  border-bottom: 3px solid #8daedc;\n  padding-bottom: 8px;\n  background-color: #ecf2f9;\n  border-radius: 15px 15px 0 0;\n}\n\n.aml-section-with-bg {\n  background: url(\"data:image/svg+xml,%3Csvg width='1600' height='120' xmlns='http://www.w3.org/2000/svg'%3E%3Cellipse fill='%23e0e9f5' fill-opacity='0.9' cx='800' cy='60' rx='650' ry='57'/%3E%3C/svg%3E\") no-repeat center 38px;\n  background-size: 93% 62px;\n  border-radius: 15px;\n  margin-bottom: 30px;\n  padding: 36px 28px 16px 32px;\n  box-shadow: 0 2px 10px rgba(120, 140, 205, 0.05);\n}\n\n.aml-section-title {\n  color: #3063b0;\n  font-size: 1.46em;\n  margin-top: 0;\n  margin-bottom: 17px;\n  font-weight: bold;\n  letter-spacing: 1px;\n  text-shadow: 0 1px 0 rgba(255,255,255,0.28);\n  display: flex;\n  align-items: center;\n}\n\n.aml-section-content {\n  color: #3a4559;\n  font-size: 1em;\n}\n\n.aml-section-content ul {\n  padding-left: 26px;\n}\n\n.aml-section-content li {\n  padding-bottom: 8px;\n  line-height: 1.62em;\n  font-size: 1em;\n}\n\n.aml-section-content strong {\n  color: #2a4374;\n}\n\n.aml-emoji {\n  font-size: 1.12em;\n  margin-left: 5px;\n  margin-right: 2px;\n}\n\n.aml-reference-list {\n  margin-top: 15px;\n  padding-left: 21px;\n  font-size: 0.96em;\n}\n\n@media screen and (max-width: 1100px) {\n  .aml-material-container {\n    padding: 16px 6vw 26px 6vw;\n  }\n}\n\n@media screen and (max-width: 700px) {\n  .aml-material-container {\n    padding: 2.3em 0.6em 2.2em 0.75em;\n    font-size: 1.08em;\n  }\n  .aml-material-title {\n    font-size: 1.35em;\n    padding: 8px 5px 8px 5px;\n  }\n  .aml-section-with-bg {\n    padding: 28px 2px 17px 9px;\n  }\n}\n\u003C/style>","\u003Cdiv class=\"aml-material-container\">\n  \u003Ch1 id=\"material_title\" class=\"aml-material-title\">急性髓系白血病用药解",525,"2025-10-25 00:15:12","阿扎胞苷, 维耐克拉, 急性髓系白血病, 安全用药, 副作用, 药物相互作用, 治疗方案","了解阿扎胞苷与维耐克拉的安全用药要点，从剂型选择到副作用监测，确保安全治疗。特别适合急性髓系白血病患者及其关心的家属。","2025-11-18 15:00:41",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]